134 related articles for article (PubMed ID: 11102893)
1. Nuclear morphometry in male breast carcinoma: association with cell proliferative activity, oncogene expression, DNA content and prognosis.
Chiusa L; Margaria E; Pich A
Int J Cancer; 2000 Nov; 89(6):494-9. PubMed ID: 11102893
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma.
Pich A; Margaria E; Chiusa L; Ponti R; Geuna M
Hum Pathol; 1996 Jul; 27(7):676-82. PubMed ID: 8698311
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 expression in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Virchows Arch; 1998 Sep; 433(3):229-35. PubMed ID: 9769126
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
Pich A; Margaria E; Chiusa L
J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
[TBL] [Abstract][Full Text] [Related]
5. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
Pich A; Margaria E; Chiusa L; Bortolin P; Palestro G
Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702
[TBL] [Abstract][Full Text] [Related]
6. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of nuclear morphometric risk grade as a prognostic factor of early breast cancer].
Watanabe T; Kimishima I; Abe R; Sano H; Furukawa Y; Nakayama K; Andou Y; Tsuchiya A
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():75-80. PubMed ID: 7747996
[TBL] [Abstract][Full Text] [Related]
10. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
[TBL] [Abstract][Full Text] [Related]
11. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
Isola J; Visakorpi T; Holli K; Kallioniemi OP
J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
[TBL] [Abstract][Full Text] [Related]
12. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma.
Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP
Int J Gynecol Cancer; 2008; 18(4):692-701. PubMed ID: 17944918
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.
Pich A; Margaria E; Chiusa L; Candelaresi G; Dal Canton O
Br J Cancer; 1999 Feb; 79(5-6):959-64. PubMed ID: 10070897
[TBL] [Abstract][Full Text] [Related]
15. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
[TBL] [Abstract][Full Text] [Related]
16. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.
Pich A; Chiusa L; Comino A; Navone R
Virchows Arch; 1994; 424(2):143-8. PubMed ID: 7910097
[TBL] [Abstract][Full Text] [Related]
18. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
Salvesen HB; Iversen OE; Akslen LA
Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]